The Meals and Drug Administration (FDA) says speedy COVID-19 antigen checks might not all the time detect the Omicron variant.
On Tuesday, the FDA launched data from analysis that means antigen checks “do detect the omicron variant but may have reduced sensitivity,” which implies an antigen take a look at might miss out on detecting the virus and find yourself giving somebody a “false negative” consequence.
The research was a collaborative effort between the FDA and the Nationwide Institutes of Well being. In line with Yahoo! Information, the 2 teams used samples from sufferers who had contracted the Omicron variant.
Whereas antigen checks might wrestle with recognizing the Omicron variant, the FDA says the checks are nonetheless good to make use of.
“The FDA continues to authorize the use of these tests as directed in the authorized labeling and individuals should continue to use them in accordance with the instructions included with the tests,” the company stated in a press release, Yahoo! Information stories. “Antigen tests are generally less sensitive and less likely to pick up very early infections compared to molecular tests.”